Trademark: 86294921
Word
GEFRELEZ
Status
Dead
Status Code
710
Status Date
Friday, February 11, 2022
Serial Number
86294921
Registration Number
4784353
Registration Date
Tuesday, August 4, 2015
Mark Type
4000
Filing Date
Thursday, May 29, 2014
Published for Opposition
Tuesday, May 19, 2015
Cancellation Date
Friday, February 11, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Feb 11, 2022
Cancelled Sec. 8 (6-Yr)
Aug 4, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 4, 2015
Registered-Principal Register
Jun 23, 2015
Teas Change Of Correspondence Received
May 19, 2015
Official Gazette Publication Confirmation E-Mailed
May 19, 2015
Published For Opposition
Apr 29, 2015
Notification Of Notice Of Publication E-Mailed
Apr 13, 2015
Law Office Publication Review Completed
Apr 1, 2015
Approved For Pub - Principal Register
Mar 11, 2015
Teas/Email Correspondence Entered
Mar 11, 2015
Correspondence Received In Law Office
Mar 10, 2015
Assigned To Lie
Mar 2, 2015
Teas Response To Suspension Inquiry Received
Nov 4, 2014
Assigned To Examiner
Sep 10, 2014
Notification Of Letter Of Suspension E-Mailed
Sep 10, 2014
Letter Of Suspension E-Mailed
Sep 10, 2014
Suspension Letter Written
Sep 6, 2014
Assigned To Examiner
Jun 11, 2014
New Application Office Supplied Data Entered In Tram
Jun 2, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24